PharmEasy
PharmEasy
Indian online healthcare company
PharmEasy is an Indian e-pharmacy company that sells medicines, diagnostics and telehealth online.[3]
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (April 2022) |
 | |
| Company type | Private |
|---|---|
| Industry | |
| Founded | 2015; 9 years ago (2015) |
| Headquarters | , India |
Number of locations | 1000+ cities in India (2021)[1] |
Area served | India |
| Services | Medicine delivery Healthcare services |
| Revenue |  ₹6,644 crore (US$830 million) (FY23)[2] |
 ₹−2,289 crore (US$−290 million) (FY23)[2] | |
| Website | www |
The company was founded in 2015 by Dharmil Sheth and Dhaval Shah in Mumbai with the initial seed funding provided by their parents.[4] The company wanted to expand beyond the Mumbai market and received their Series A funding.
In May 2021, PharmEasy acquired rival e-pharmacy company Medlife for an undisclosed amount.[5] In June 2021, the company acquired a 66.1% stake in diagnostics chain Thyrocare for ₹4,546 crore (US$613.5 million).[6][7] In September 2021, it acquired a majority stake in Aknamed, a healthcare supply chain company.[8]
In November 2021, the company filed papers to launch its initial public offering (IPO) of ₹6,250 crore (US$843.46 million).[9] The company withdrew its IPO plans in August 2022.[10]
PharmEasy competes with other e-pharmacy companies including Netmeds (which was acquired by Reliance Industries), 1mg (acquired by Tata Group), Apollo 24x7 and Amazon Pharmacy.[11] The Ken questioned the company's positioning as a unified healthtech player and referred to the company's story as "more confusing than convincing".[12]
Medlife–PharmEasy merger protests
In 2020, PharmEasy and Medlife were in merger talks which came to the attention of the Competition Commission of India (CCI), which approves such mergers. The merger was protested by The South Chemist and Distributors Association (SCDA), who objected that sales of medicines online was illegal in India. The online sales of medicines was later regulated and the merger was completed in 2021.[13][14]
PharmEasy advertisement
Members of the Hindu religion criticized one of the company's advertisements and said that religious sentiments were hurt for the sake of marketing and sales. The advertisement in question showed Lakshman being struck and Ram needing Sanjeevani, asking who will bring the medicine from such a long distance. Two PharmEasy employees arrive by scooter to deliver it.[15]
- "PharmEasy official site". Retrieved 3 July 2021.
- "PharmEasy's scale crosses Rs 6,600 Cr in FY23; losses down 16%". Entrackr. Retrieved 10 March 2024.
- ""Built A Strong Backend Before A Good Frontend"". www.fortuneindia.com. Retrieved 6 November 2021.
- Datta, PT Jyothi (August 2021). "The charge of the young brigade from PharmEasy". @businessline. Retrieved 6 November 2021.
- "PharmEasy acquires Medlife, becomes India's largest e-pharma company". Business Standard. Retrieved 5 July 2023.
- "PharmEasy: A tryout's journey through tests to the Thyrocare takeover". cnbctv18.com. 27 June 2021. Retrieved 6 November 2021.
- "PharmEasy buys out Thyrocare for ₹4,546 cr". The Hindu Businessline. 25 June 2021. Retrieved 5 July 2023.
- "PharmEasy buys majority stake in healthcare supply chain start-up Aknamed". Business Standard. Retrieved 5 July 2023.
- Mudgill, Amit (10 November 2021). "PharmEasy parent API Holdings files draft papers for Rs 6,250 crore IPO". The Economic Times. Retrieved 5 July 2023.
- "PharmEasy parent recalls draft IPO papers, weighs rights issue to raise funds". Moneycontrol. 20 August 2022. Retrieved 5 July 2023.
- "PharmEasy-Medlife Merger May Hit CCI Hurdle As Chemist Association Protests". Inc42 Media. 18 September 2020. Retrieved 6 November 2021.
- "PharmEasy's theory of healthtech: Unified or confused?". The Ken. 5 October 2021. Retrieved 6 November 2021.
- John Sarkar (26 May 2021). "Pharmeasy Medlife acquisition: PharmEasy buys Medlife, to be no. 1 e-health entity | India Business News - Times of India". The Times of India. Retrieved 6 November 2021.
- "What Went Wrong At PharmEasy And Can It Find A Cure?". Forbes India. Retrieved 25 October 2023.
- www.ETBrandEquity.com. "2019 in review: When brands courted controversy on social media - ET BrandEquity". ETBrandEquity.com. Retrieved 6 November 2021.